Snowball logo
logo
4521

Kaken Pharmaceutical Co Ltd

4521 TSE
¥3,680.00¥0.00  (0%)

Frequently asked questions

What sector does Kaken Pharmaceutical Co Ltd (4521) operate in?

Kaken Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Kaken Pharmaceutical Co Ltd (4521) current stock price?

As of the latest data, Kaken Pharmaceutical Co Ltd stock price is ¥3,680, with a previous close of ¥3,680.

What is Kaken Pharmaceutical Co Ltd (4521) current market capitalization?

Kaken Pharmaceutical Co Ltd market cap is approximately 140.09 billion.

What is Kaken Pharmaceutical Co Ltd (4521) Earnings Per Share (EPS)?

The trailing EPS is ¥366.

What is Kaken Pharmaceutical Co Ltd (4521) Price-to-Earnings (P/E) ratio?

Kaken Pharmaceutical Co Ltd current P/E ratio is 10.07.

What is Kaken Pharmaceutical Co Ltd (4521) EBITDA?

Kaken Pharmaceutical Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 1.06 billion.

Does Kaken Pharmaceutical Co Ltd (4521) pay dividends?

Yes. Kaken Pharmaceutical Co Ltd pays semiannual dividends with an annualized yield of 5.16% and an estimated annual payout of ¥190 per share.

When is the next ex-dividend date for Kaken Pharmaceutical Co Ltd (4521)?

The next ex-dividend date is scheduled for March 29, 2026.

When is Kaken Pharmaceutical Co Ltd (4521) next earnings report?

Kaken Pharmaceutical Co Ltd is expected to release its next earnings report on September 30, 2025.

What is Kaken Pharmaceutical Co Ltd (4521) beta (volatility) score?

Kaken Pharmaceutical Co Ltd has a beta of 0.051, indicating lower volatility than the overall market.